Zimmer Biomet to Present at BofA Securities 2021 Virtual Health Care Conference
News provided by
Share this article
Share this article
WARSAW, Ind., April 27, 2021 /PRNewswire/ Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021, at 12:30 p.m. Eastern Time.
A live webcast of the presentation can be accessed via Zimmer Biomet s Investor Relations website at https://investor.zimmerbiomet.com. The webcast will be archived for replay following the conference.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Teleflex to Present at the Bank of America Securities 2021 Virtual Health Care Conference
Teleflex IncorporatedApril 27, 2021 GMT
WAYNE, Pa., April 27, 2021 (GLOBE NEWSWIRE) Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 8:00 a.m. (ET).
A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor portion of the Teleflex website at www.teleflex.com.
About Teleflex Incorporated
Share this article
Share this article
ALAMEDA, Calif., April 27, 2021 /PRNewswire/ Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021.
Event: BofA Securities 2021 Virtual Health Care Conference
Date: Tuesday, May 11, 2021
Time: 11:45am ET / 8:45am PT
A webcast of the presentation will be available by visiting the investors section of the company s website at www.penumbrainc.com. The webcast will be available on the company s website for at least two weeks following the event.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals